Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours ยท Estimated delivery Aug 23 - Aug 28
Potential side effects include headaches, sweating, hypertension, insomnia, and agitation
Mechanisms such as increasing cellular antioxidant enzymes, stabilizing membranes, supporting DNA and mitochondrial repair, and modulating inflammatory cytokines suggest that peptides target multiple pathways for more impact
FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway [PMID: 41625068] Laboratory literature summary: FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway
As of 2024, retatrutide has not received MHRA or EMA marketing authorisation and is not listed in the BNF
Product Features Compound: Retatrutide + Cagrilintide Concentration: 12.5mg / 2.5mg Form: Freeze-dried (lyophilized) powder Packaging: Single vial Purity: 99% Intended Use This product is for research and development purposes only
00014-3/asset/416915f8-7d8e-4d73-b09f-ed12ab1bc489/main.assets/gr2.jpg)
